It is well established that insulin affects a number of processes involved in mammalian lipid metabolism. It stimulates the synthesis of fatty acids de now (lipogenesis) in liver, adipose tissue (white and brown), intestine and lactating mammary gland. The activity of lipoprotein lipase (EC 3.1.1.34) in white adipose tissue is increased by the hormone and therefore the uptake and re-esterification of non-esterified fatty acids (NEFA) released from plasma triacylglycerols (chylomicrons derived from the intestine and very-lowdensity Lipoproteins from the liver and, to a lesser extent, the intestine) is promoted. Storage of these fatty acids in the adipose tissue depots is ensured by the antilipolytic action of the hormone. Consequently, a decrease in plasma insulin results in mobilization of fatty acids from adipose tissue, increased uptake of fatty acids by the liver and synthesis of ketone bodies for export to peripheral tissues, particularly the brain. Simultaneously, there is a decrease in lipoprotein lipase activity in adipose tissue, but no change or an increase in activity in skeletal muscle, so that plasma triacylglycerol is directed to this tissue. In addition, a lower plasma insulin results in inhibition of lipogenesis in liver, intestine and white and brown adipose tissue.
Detailed aspects of the action of insulin on hepatic triacylglycerol synthesis [I, 21, the regulation of adipose tissue lipoprotein lipase activity [3] and the anti-lipolytic effects of the hormone [4] are discussed by other contributors to this Colloquium. The intention in this contribution is to describe the general effects of the decrease of plasma insulin in experimental diabetes (Table 1) on the integration of lipid and, in particular, triacylglycerol metabolism, and to compare these changes with those that occur in two other situations associated with relative hypoinsulinaemia, namely starvation and lactation. Diabetes (e.g. a raised fasting blood glucose) can occur without a decrease in plasma insulin if there is resistance to the action of the hormone, but this type of diabetes will not be discussed here.
Experimental diabetes (insulin deficiency)
The most common method of producing insulin deficiency in experimental animals is the use of a diabetogenic agent (alloxan or streptozotocin) which will damage or destroy the B-cells of the pancreas. StreDtozotocin appears Abbreviation used: NEFA, non-esterified fatty acids.
to have replaced alloxan as the agent of choice because its effects are more reproducible. The effects of streptozotocin on the P-cell occur in three stages: initially it inhibits insulin secretion (2-3 h) with accompanying hyperglycaemia; this is followed by profound hypoglycaemia resulting from the release of stored insulin (7-12 h) and finally an irreversible diabetic state (24 h) [ 5 , 61. In the rat, the effects of the drug are dose related [6, 71 and therefore varying degrees of insulin deficiency can be produced with different metabolic effects ( Table 2 ). High doses ( > 100 mg/kg body wt.) of streptozotocin produce a metabolic profile of hyperglycaemia, hyperketonaemia and hyperlipidaemia in the rat [7] which resembles the ketoacidosis of insulin-dependent diabetes mellitus (type l diabetes). Without exogenous insulin there is a high mortality and therefore streptozotocin-treated rats are often maintained on insulin and this is then withdrawn before the experiment [8] . The severity of the metabolic changes results in hypophagia [8] and these rats are often studied in the partially starved or starved state.
In contrast, sublethal doses of the drug ( < 70 mg/kg body wt.) produce hyperphagia in rats [9, 101. These rats have hyperglycaemia, an impaired glucose tolerance, but rarely show ketonuria or hyperketonaemia. The latter finding is likely to be mainly due to the considerable loss of adipose tissue [ 111 and therefore an inability to mobilize non-esterified fatty acids for partial oxidation to ketone bodies in the liver. This type of insulin-deficient rat has therefore some of the characteristics of non-ketotic hyperglycaemic diabetes mellitus [12] , including loss of skeletal muscle and adipose tissue [l 11. It is of interest that the hyperphagia occurs when the diet is high in carbohydrate, but not when the composition of the diet is isocaloric [13] . This may be explained by the large loss of glucose via urinary excretion on the high carbohydrate diet. The hyperphagia in this model of diabetes is accompanied by hypertrophy of the intestine [lo, 11, 13, 141, although this can occur in the absence of hyperphagia [ 10, 131, and increased intestinal lipid metabolism. -Acute effects of insulin deficiency can be studied by injection of anti-insulin serum to bind the plasma insulin [15, 161. A similar lowering of plasma insulin can be achieved for the first 3 h after injection of streptozotocin [17] .
Two interesting genetic models of diabetes have been described in the rat. The BB/Wistar rat develops a spontaneous diabetes with many of the characteristics, including wasting of body tissues (muscle protein and adipose tissue), dehydration, hyperglycaemia and ketosis, of insulin-dependent diabetes mellitus [ 18, 191 . The SHR/N-corpulent rat develops insulin-independent diabetes and hyperlipidaemia [20, 211; it can be considered a model for non-insulin dependent diabetes mellitus (Table 1) .
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In starvation there is a four-fold decrease in plasma insulin, an increase in plasma NEFA and blood ketone bodies, but no change in plasma triacylglycerol ( Table 2 ). The hypoinsulinaemia in starvation results in increased lipolysis in adipose tissue and therefore increased flux of NEFA to the liver. Within the liver, the decreased plasma insulin causcs an inhibition of lipogenesis [22] with a subsequent decrease in malonyl-CoA concentration, which in turn allows the increased entry of fatty acyl-CoA into the mitochondria via the carnitine palmitoyltransferase system for oxidation to ketone bodies [23, 241 . The rate of entry of triacylglycerol into the circulation is not greatly altered in the starved compared with the fed state [25, 261 and as there is little change in the plasma triacylglycerol in the two situations [25, 261 (Table 2) it would seem reasonable to assume that the rate of triacylglycerol removal is similar.
The severely insulin-deficient diabetic rat (high dose streptozotocin) is characterized by concentrations of NEFA, ketone bodies and triacylglycerols in the circulation which are three-to ten-fold higher than in the starved (48 h ) rat [7, 81 (Table 2) . If these concentrations are expressed as longchain fatty acid equivalents, the plasma triacylglycerol of the diabetic rat is six-fold higher than that of plasma NEFA or blood ketone bodies, whereas the corresponding value for the starved rat is only two-fold higher. The entry rate of triacylglycerols in severely diabetic rats is decreased by 55% [27], which suggests that the rate of removal must be depressed to explain the large increase in plasma triacylglycerols. Similarly, acute insulin deficiency induced by antiinsulin serum results in an immediate increase in plasma NEFA and blood ketone bodies, followed by an increase in plasma triacylglycerols some 6-8 h later [16] . Although the rate of triacylglycerol entry in vivo was not measured in these experiments, the output of triacylglycerol from livers of antiinsulin-serum-treated rats (6-8 h) perfused with NEFA was greatly depressed [ 16) . These findings support the view that there is decreased removal of triacylglycerols in insulin-deficient diabetes.
The key determinant in controlling the rcmoval of triacylglycerol from the circulation is the activity of lipoprotein lipase at the endothelial cell surface [3] , which in the case of white adipose tissue is positively correlated to the plasma insulin [28] . Recent measurements of total tissue lipoprotein lipase activity in rat tissues confirms the view that in the fed state the activity in adipose tissue (some 80% of the total body activity) is more important than in skeletal muscle (18%) [29] . In starvation, the activity of the enzyme in adipose tissue decreases by 75%, whereas the activity in muscle is unchanged and this tissue becomes potentially more important than adipose tissue for triacylglycerol removal. The tissue-specific changes in the activity of lipoprotein lipase are similar in streptozotocin-diabetic rats [29] . On the basis of these findings it would appear that the lower, but similar, capacity for triacylglycerol removal in the starved and diabetic rats cannot explain the hypertriglyceridaemia in the latter group. It must, however, be emphasized that the whole tissue activity of lipoprotein lipase may not be representative of that on the endothelial cell surface [26] . An alternative explanation for the decreased removal of 
Lipid metabolism arid the hypoinsulinaemia of lactation
Lactation in the rat, like starvation and experimental diabetes, is associated with depressed lipid metabolism in white adipose tissue (see [32] [33] [34] [35] ), despite the accompanying hyperphagia. The changes include a decrease in lipoprotein lipase activity in white adipose tissue which is accompanied by decreased accumulation of exogenous I'C-lipid [35] and a decrease in the rate of lipogenesis. The net result is that adipose tissue is in lipolytic mode during lactation. These changes are all reversed on removal of the litter for 24-48 h and it has been suggested that prolactin production may play a role in depressing lipid metabolism in white adipose tissue during lactation [32-341. However, any effect of prolactin must be indirect because receptors for the hormone have not been detected in adipose tissue [33] .
In contrast to adipose tissue, the mammary gland of the lactating rat has a high rate of lipogenesis [32, 331, high activity of lipoprotein lipase [34] and accumulates a high proportion of an exogenous 14C-lipid load [35] . Thus the lactating mammary gland has a high rate of lipid metabolism and this is necessary to support the secretion of lipid in milk. The tissue-specific alteration of lipid metabolism in lactation results in a decreased oxidation of dietary lipid [35] (Table 3) . This 'sparing' of lipid continues in the immediate period after removal of the litter, but now the white adipose tissue is the major tissue of lipid accumulation [35] (Table 3) .
The fed lactating rat has a plasma insulin which is approximately 50% lower than that of the non-lactating rat [32, 331 and an important question is whether this relative hypoinsulinaemia plays a role in the changes in lipid metabolism, particularly in the white adipose tissue during lactation. Present evidence suggests that lipogenesis in the lactating gland is highly sensitive to food intake [36] and the plasma insulin [37] . However, starvation for 24 h only produces a 60% decrease in I4C-lipid uptake by the lactating mammary tissue [38] , whereas lipogenesis is inhibited 95% under the same conditions [37] . Refeeding restores the rates of both processes, but administration of mannoheptulose to decrease plasma insulin on refeeding prevents the increase in lipogenesis in mammary tissue [17], but does not affect the restoration of ''C-lipid uptake [38] (Table 3 ). The apparent lack of dependence of I4C-lipid accumulation (and the activity of lipoprotein lipase) in the mammary gland on the plasma insulin means that triacylglycerol can still be extracted by the gland when plasma insulin decreases in the postabsorptive state [37] .
Removal of the litter for 24 h results in a 10-fold increase in ("C-lipid accumulation in the white adipose tissue mass and a corresponding decrease in mammary tissue [35] (Table  3) . This large increase in accumulation in white adipose tissue is accompanied by hyperinsulinaemia. Starvation for 24 h after removal of the litter lowers plasma insulin and prevents the switch-on of lipoprotein lipase activity and hence '"C-lipid accumulation in adipose tissue [38] . Refeeding ad libitum for 2 h restores the uptake of 14C-lipid into adipose tissue (Table 3 ) and this can be prevented by mannoheptulose treatment [38] . Thus there is a good correlation between the plasma insulin and the accumulation of lipid in adipose tissue on removal of the litter, as has been shown in non-lactating rats [28] . Maintaining endogenous prolactin secretion by teat-sealing does not prevent the switch-on of adipose tissue lipid metabolism (C. M. Oller do Nascimento & D. H. Williamson, unpublished work). The high rate of deposition of lipid in adipose tissue after cessation of lactation allows rapid restoration of the adipose tissue mass and this appears to be mainly due to the hyperinsulinaemia (Table 3) .
Despite the hyperphagia, the relative hypoinsulinaemia and the decrease of lipoprotein lipase activity in the adipose tissue during lactation, hypertriglyceridaemia does not occur. The reason is that the lactating mammary gland represents a new site for triacylglycerol removal and although lipoprotein lipase activity and lipid accumulation in this tissue are decreased on starvation, it is less sensitive to food intake than adipose tissue. Consequently, in starvation there is presumably sufficient capacity of lipoprotein lipase in skeletal muscle and the lactating mammary gland to prevent an increase in plasma triacylglycerols [39] , even though the liver of the starved lactating rat converts a higher proportion of NEFA to esterified products [40,41 I. Lipoprotein lipase (LPL; EC 3. I . 1.34) is the enzyme responsible for the hydrolysis of the triacylglycerols of the plasma chylomicron and very-low-density lipoproteins. Through its action it makes the triacylglycerol fatty acids available to the extrahepatic tissues of the body for either oxidation, as in muscle, or for storage, as in adipose tissue. The enzyme is synthesized within the parenchymal cells of the extrahepatic tissues and is then transferred to the luminal surfaces of the capillary endothelial cells where hydrolysis of the lipoprotein triacylglycerols takes place (Robinson, 1970) . Although the route of the enzyme's transfer from the site of its synthesis to its functional site is imperfectly understood (see below), it is known to be held at the endothelial cell surface by ionic interactions with heparan sulphate residues of the plasma membrane proteoglycans (Olivecrona et af., 1977) .
The LPL activity of particular extrahepatic tissues changes with changes in physiological and pathological state and such changes are often paralleled by corresponding variations in the uptake of plasma triacylglycerol fatty acids by the same tissues (see Speake et al., 1985a and reviews in Borensztajn, 1987) . For example, in adipose tissue, LPL activity and triacylglycerol fatty acid uptake are both high in the fed state Abbreviation used: LPL, lipoprotein lipase ( E C 3.1. I .34).
but fall on fasting (as they also do in diabetes). On the other hand, in skeletal and heart muscle, triacylglycerol fatty acid uptake and the activity of the enzyme are both increased in the fasting state in order to provide fatty acids for oxidation; presumably for similar reasons, both also rise in muscle during severe prolonged exercise. Again, the mammary gland removes very little triacylglycerol fatty acid from the blood throughout pregnancy but, at parturition, uptake increases markedly in order to provide fatty acids for the milk triacylglycerols. At the same time, there is a dramatic rise in the LPL activity of the gland and it and the triacylglycerol fatty acid uptake remain high throughout lactation and fall again at weaning.
Such tissue-specific changes in LPL activity strongly suggest that the enzyme not only facilitates but also directs triacylglycerol fatty acid removal from the blood so as to provide for the changing requirements of individual body tissues (Robinson, 1970) . All the available evidence indicates, moreover, that they are primarily the result of hormonal control (see Borensztajn, 1987) . So far as the reciprocal changes such as those in adipose tissue and muscle are concerned, such control must be tissue differential. A number of mechanisms whereby this might be achieved can be envisaged, including tissue-specific receptor distribution or gene regulation. However, there is little firm evidence for any of the various possibilities at the present time. Our knowledge of the mechanisms of control of the enzyme's activity within a single tissue is somewhat more
